Controlling Molecules From Tea to Advanced Bioreactors
Deniz Kent, CEO of Prolific Machines, shares his journey of raising over $90M from top-tier investors, including Series B+ rounds. He discusses his strategies for securing capital and his company's pivot from cultured meat to therapeutic proteins.
Watch on Startup Fundraising · Open on YouTube ·
More shorts